Ascletis And Suzhou Alphamab Expand Their Partnership Into Worldwide License Agreement For ASC22…
Ascletis Pharma Inc. (1672.HK) and Suzhou Alphamab Co., Ltd. jointly announce today that Ascletis' subsidiary and Suzhou Alphamab have entered into an…